Recombinant Human TNF-β

Recombinant Human TNF-β

Product No.: T154

[product_table name="All Top" skus="T154"]

- -
- -
Alternate Names
Tumor Necrosis Factor-Beta, Lymphotoxin-Alpha (LT Alpha), Tumor Necrosis Factor Ligand Superfamily Member 1, Lymphotoxin Alpha 3
Product Type
Recombinant Protein
Expression Host
E. coli Cells
Species
Human

- -
- -
Select Product Size

Data

- -
- -

Background

Tumor necrosis factor-beta (TNF-β), also known as LT-α and TNFSF1, is a highly inducible, secreted protein and member of the TNF ligand superfamily. It mediates a large variety of inflammatory, immunostimulatory and antiviral responses (1). TNF-β is also involved in the formation of secondary lymphoid organs during development and plays a role in apoptosis (1). It forms heteromers with lymphotoxin-beta (LT-β) that anchor the complexes to the cell surface of activated T, B and LAK cells (2). TNF-β and TNF-α are structurally and functionally related proteins that bind to the same cell surface receptors (TNF RI and TNF RII) and produce a wide range of similar effects (3). TNF-β promotes the proliferation of fibroblasts and induces the synthesis of GM-CSF, G-CSF, IL-1, collagenase and prostaglandin E2 (4). In neutrophils, it induces the production of reactive oxygen species, increases phagocytosis and adhesion to the endothelium, as well as acting as a chemoattractant for these cells. TNF-β is a mitogen for B-lymphocytes while it inhibits the growth of osteoclasts and keratinocytes. It is cytoxic or cytostatic for many tumor cells (6). TNF-β has been implicated in the pathogenesis of several autoimmune diseases and it plays a significant role in the etiopathogenesis of multiple sclerosis (7). Genetic variations in this gene are associated with susceptibility to leprosy type 4 and psoriatic arthritis. TNF-β may also be involved in processes of wound healing.

Protein Details

Purity
>95% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<0.01EU/µg as determined by the LAL method
Biological Activity
The biological activity of Human Tumor Necrosis Factor-Beta is determined by the cytolysis of mouse L929 cells in the presence of Actinomycin D. The expected ED<sub>50</sub> for this effect is 2 x 10<sup>7</sup> units/mg.
Protein Accession No.
Amino Acid Sequence
mlpgvgl tpsaaqtarq hpkmhlahst lkpaahligd pskqnsllwr antdraflqd gfslsnnsll vptsgiyfvy sqvvfsgkay spkatssply lahevqlfss qypfhvplls sqkmvypglq epwlhsmyhg aafqltqgdq lsthtdgiph lvlspstvff gafal
N-terminal Sequence Analysis
Met
State of Matter
Lyophilized
Predicted Molecular Mass
The predicted molecular weight of Recombinant Human TNF-β is Mr 19 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE is Mr 17-19 kDa (reducing conditions).
Predicted Molecular Mass
19
Formulation
This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.
Storage and Stability
The lyophilized protein should be stored desiccated at -20°C. The reconstituted protein can be stored for at least one week at 4°C. For long-term storage of the reconstituted protein, aliquot into working volumes and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
NCBI Gene Bank

References & Citations

1. Adolf, GR. et al. (1990) Infec. Immun. 58:3996
2. Trinchieri, G. et al. (1992) Immunol. Ser. 56:289
3. Dembic, Z. et al. (1990) Cytokine 2:231
4. Oster, W. et al. (1987) Blood. 70:1700
5. Broudy, VC. et al. (1987) J. Immunol. 138:4298
6. Pagliacci, MC. et al. (1993) Lymph. Cyto. Res. 12:439
7. Pandey, JP. et al. (2002) Autoimmunity 35:377

Certificate of Analysis

IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.